AllNewsPhotosVideos
Serum Institute of India

Serum Institute Of India Private Ltd.

Serum institute of india private ltd., Latest News

Serum Institute of India is an Indian biotechnology and biopharmaceuticals company. It is the world's largest vaccine manufacturer. It is located in the city of Pune, Maharashtra, India, and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries.
Read More
Vaccine taken should not put individual at disadvantage, says Estonia Ambassador - Hindi News | Vaccine taken should not put individual at disadvantage, says Estonia Ambassador | Latest national News at Lokmattimes.com

National :Vaccine taken should not put individual at disadvantage, says Estonia Ambassador

People often cannot choose what vaccine they get and a vaccine should not put a person at disadvantage if it is approved and is in use, Estonia Ambassador to India Katrin Kivi said on Friday. ...

Netherlands becomes latest EU country to approve Covishield vaccine - Hindi News | Netherlands becomes latest EU country to approve Covishield vaccine | Latest international News at Lokmattimes.com

International :Netherlands becomes latest EU country to approve Covishield vaccine

The Netherlands became the latest European Union (EU) country to approve the Serum Institute of India (SII)-manufactured Covishield vaccine for travellers, days after India pushed for the approval of its COVID-19 vaccines in Europe. ...

Covishield will get EMA approval in a month, says Adar Poonawala at Indian Global Forum 2021 - Hindi News | Covishield will get EMA approval in a month, says Adar Poonawala at Indian Global Forum 2021 | Latest national News at Lokmattimes.com

National :Covishield will get EMA approval in a month, says Adar Poonawala at Indian Global Forum 2021

Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's CEO Adar Poonawalla informed on Wednesday. ...

EU travel issues faced by Indians given Covishield taken up at 'highest level', says Adar Poonawalla - Hindi News | EU travel issues faced by Indians given Covishield taken up at 'highest level', says Adar Poonawalla | Latest national News at Lokmattimes.com

National :EU travel issues faced by Indians given Covishield taken up at 'highest level', says Adar Poonawalla

Adar Poonawalla, Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Monday assured Indians who have taken Covishield doses and are now facing issues while travelling to European Union countries that the matter had been e ...

SII to conduct clinical trials of Novavax for children - Hindi News | SII to conduct clinical trials of Novavax for children | Latest health News at Lokmattimes.com

Health :SII to conduct clinical trials of Novavax for children

New Delhi, June 17 The Serum Institute of India is likely to launch clinical trials of the Novavax ... ...

Nepal to procure 4mn vaccines from China under non-disclosure deal - Hindi News | Nepal to procure 4mn vaccines from China under non-disclosure deal | Latest health News at Lokmattimes.com

Health :Nepal to procure 4mn vaccines from China under non-disclosure deal

Kathmandu, June 17 The Nepal government has decided to procure four million Covid-19 vaccines manufactured by China's Sinopharm ... ...

Himachal procures vaccine from Serum Institute - Hindi News | Himachal procures vaccine from Serum Institute | Latest health News at Lokmattimes.com

Health :Himachal procures vaccine from Serum Institute

Shimla, June 13 Himachal Pradesh has procured Covishield vaccine from the Serum Institute of India (SII) and the ... ...

No changes as of now in gap between Covishield doses, say govt sources - Hindi News | No changes as of now in gap between Covishield doses, say govt sources | Latest national News at Lokmattimes.com

National :No changes as of now in gap between Covishield doses, say govt sources

Amid calls to reduce the gap between two doses of Serum Institute of India's COVID-19 vaccine Covishield based on the new findings by Public Health England, the Central government will not take the decision to change the dosage interval immediately, ...